Oral Statin Therapy in KRT16 ‐ and KRT17 ‐Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita)
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17900 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Sota Itamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Pachyonychia Congenita, Keratin-16, Keratin-17, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 15 Literaturangaben. Gefördert von: National Cheng Kung University Hospital.
Abstract (Originalsprache)
Palmoplantar epidermal differentiation disorder associated with pachyonychia congenita (pEDD‐PC) is a rare autosomal dominant skin disorder caused by pathogenic variants in keratin genes, including KRT6A , KRT6B , KRT6C , KRT16 , and KRT17 . While statins have been reported to alleviate symptoms in KRT6A ‐pEDD‐PC, their efficacy in other subtypes remains unclear. We report six adult patients, including four with KRT17 variants and two with KRT16 variants, who underwent off‐label oral statin therapy. Statins were administered for at least 6 months following dose stabilization. Although the treatment was well tolerated in most cases, no significant clinical improvement in plantar calluses or pain was observed. All patients discontinued therapy due to insufficient efficacy. Our findings indicate that oral statin therapy may offer limited benefit in KRT16 / KRT17 ‐pEDD‐PC and suggest the potential importance of early intervention and genotype‐specific therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Dermatology, National Cheng Kung University Hospital, Tainan, Taiwan.
- International Center for Wound Repair and Regeneration (iWRR), National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Sota Itamoto, Wei-Ting Tu, Mika Watanabe, Hideyuki Ujiie, Chao-Kai Hsu, Ken Natsuga
Förderung
- National Cheng Kung University Hospital
Zitieren
APA
Itamoto, S., Tu, W. T., Chang, C. Y., Watanabe, M., Ujiie, H., Hsu, C. K., & Natsuga, K. (2025). Oral Statin Therapy in KRT16 ‐ and KRT17 ‐Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita). The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17900
Vancouver
Itamoto S, Tu WT, Chang CY, Watanabe M, Ujiie H, Hsu CK, et al. Oral Statin Therapy in KRT16 ‐ and KRT17 ‐Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita). The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17900
BibTeX
@article{Itamoto2025,
author = {Itamoto, Sota and Tu, Wei-Ting and Chang, Chih-Yu and Watanabe, Mika and Ujiie, Hideyuki and Hsu, Chao-Kai and Natsuga, Ken},
title = {Oral Statin Therapy in KRT16 ‐ and KRT17 ‐Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita)},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17900}
}
EUVIMED